(1R,4R,5S)-4-(2-Chloroethyl)-1-[(S)-(1S)-2-cyclohexen-1-ylhydroxymethyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione-d4; (-)-Salinosporamide A-d4; Salinosporamide A-d4 ;Marizomib (Salinosporamide A)-d4
Marizomib (Salinosporamide A)-d4 is a fully characterized chemical compound used as a reference standard of API Marizomib. The standard offered is compliant with regulatory guidelines. Marizomib (Salinosporamide A)-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 437742-34-2 (non-d)
